Combination of erlotinib and naproxen employing pulsatile or intermittent dosing profoundly inhibits urinary bladder cancers
Mohammed, Altaf, Miller, Mark Steven, Lubet, Ronald A, Suen, Chen S, Sei, Shizuko, Shoemaker, Robert H., Juliana, Margaret M, Moeinpour, Fariba L, Grubbs, Clinton J.Journal:
Cancer Prevention Research
DOI:
10.1158/1940-6207.CAPR-19-0339
Date:
December, 2019
File:
PDF, 1.86 MB
2019
File converter
More search results
More benefits 
